Tenax Therapeutics (TENX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 04-2001 | 12-2000 | 04-2000 | 12-1999 | 04-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,672 | N/A | -911 | -910 | 0 |
| Depreciation Amortization | 72 | 70 | 54 | 50 | 0 |
| Accounts receivable | -12 | N/A | -10 | N/A | 0 |
| Other Working Capital | -177 | -140 | -120 | -120 | 0 |
| Other Operating Activity | 222 | 200 | 74 | 70 | 0 |
| Operating Cash Flow | $-1,568 | $130 | $-913 | $-910 | $0 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -240 | -240 | -18 | -10 | 0 |
| Purchase Sale Intangibles | -47 | N/A | N/A | N/A | 0 |
| Other Investing Activity | -47 | 0 | -34 | -40 | 0 |
| Investing Cash Flow | $-288 | $-240 | $-52 | $-50 | $0 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 135 | N/A | N/A | N/A | 0 |
| Debt Repayment | N/A | N/A | -84 | N/A | 0 |
| Common Stock Issued | 507 | N/A | 6,380 | N/A | 0 |
| Other Financing Activity | -2 | 630 | -57 | 6,230 | 0 |
| Financing Cash Flow | $640 | $630 | $6,239 | $6,230 | $0 |
| Beginning Cash Position | 5,466 | N/A | 193 | 190 | 0 |
| End Cash Position | 4,251 | N/A | 5,466 | 5,460 | 0 |
| Net Cash Flow | $-1,216 | $520 | $5,273 | $5,270 | $0 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,568 | 130 | -913 | -910 | 0 |
| Capital Expenditure | -240 | N/A | -18 | N/A | 0 |
| Free Cash Flow | -1,808 | 130 | -931 | -910 | 0 |